Groups of patients with lepromatous and tuberculoid leprosy and hospital staff from six leprosaria in East Africa and 'non-contact' groups of villagers or staff from general hospitals have been skin tested with 10 reagents. These were prepared by ultrasonic disintegration from M. tuberculosis, M. duvalii, M. chelonei and 7 other species identified in the Ugandan environment. Comparisons were made of the percentages of positive reactors in each study group for each reagent. The 'specific' defect of lepromatous patients was found to apply to a variable extent to six of the species tested, but not to M. tuberculosis, M. avium or M. 'A*'. The defect applied most noticeably to M. nonchromogenicum and M. vaccae, suggesting that they are more closely related to M. leprae than are the other species tested. The reagent Chelonin produced unexpected and anomalous results in the lepromatous group. It is suggested that this was due to an unusually slow clearing of Arthus' reaction.
INTRODUCTION
It has long been recognized that a deficiency in immunity is associated with lepromatous leprosy and it has more recently been demonstrated that a degree of this deficiency also occurs in tuberculoid patients (Bullock, 1968) . Studies on leprosy contacts have shown that the lymphocytes of healthy people may transform markedly in the presence of whole leprosy bacilli (Godal & Negassi, 1973) , indicating that subclinical infection occurs and probably conveys some degree of protection. Whether the immune deficit present in the disease is a predisposing factor in its development, or the result of the infection, remains uncertain. It has been suggested that the macrophage of the lepromatous patient is inherently unable to destroy leprosy bacilli (Beiguelman, 1967) . Alternatively the apparent macrophage defect may reflect the absence of a circulating clone of thymic (T) lymphocytes reactive to the leprosy organism. In polar cases of lepromatous (LL) leprosy this clone may never have existed; it may have been totally ablated by antigen overload or its activity may have been suppressed perhaps in a manner https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022172400047069 analogous to that which apparently occurs in the early phase of M. ulcerans infection. Amongst sub-polar lepromatous cases which have the ability to upgrade, that is move towards the tuberculoid end of the disease spectrum, some residuum of an effective T-cell clone must exist either as an antigen-resistant precursor or possibly as potent cells trapped in the lymph nodes. Whatever the explanation it seems likely that reactivity to other organisms closely related to the leprosy bacillus might also be impaired; in fact there is already some evidence for this (Godal, Myrvang, Stanford & Samuel, 1974) . As an extension of this it might be postulated that the amount of incompetence in the handling of an organism by leprosy patients could be used as a measure of the relation between that organism and the leprosy bacillus. To assess this possibility tuberculins have been prepared from ten species of mycobacteria and these have been used to skin-test groups of leprosy patients, leprosaria staff and others in East Africa.
Somewhat similar studies carried out by Pinto, Arseculeratne & Welianga (1973) in Ceylon failed to demonstrate differences in response between the two immunological extremes of leprosy. However, they used PPD's of five species of mycobacteria, only one of which (M. fortnitum) was a fast growing species.
MATERIALS AND METHODS
The skin test antigens used in this study were prepared from the organisms listed in Table 1 . With the exception of M. tuberculosis, M. duvalii and M. chelonei all the mycobacteria used were isolated from the Ugandan environment (Stanford & Paul, 1973) ; six of these were of named species and one was of a new slow growing species, referred to as M. 'A*'.
For the preparation of each reagent 100 ml. quantities of Sauton's medium in 11. flat bottles were inoculated with mycobacteria grown on Lowenstein Jensen medium. The cultures were incubated at 32° C. for several weeks and the growth on them was used to inoculate 800 ml. quantities of Sauton's medium in Thompson flasks. When good growth had been obtained, the organisms were harvested by centrifugation at 20,000 g for 15 min. and the medium was discarded. The organisms were washed twice with 2 vol. M/15 phosphate buffer (pH 6-8) and suspended in approximately 50 ml. of the same buffer. These suspensions were then treated for 15 min. in an M.S.E. 100 watt ultrasonic disintegrator with the wave peak distance set at 8-9 ^m. Extracts produced were centrifuged at 70,000 g for 30 min. and the supernatants were serially filtered through three sterile membrane filters, one with a pore size of 0-45 fim. and two with pore sizes of 0-22 fim. Small amounts of the concentrated sonicated extracts were tested for confirmation of identity against rabbit antisera to the species under test in an immunodiffusion system. The resultant filtrates were tested for sterility on Lowenstein Jensen medium and protein concentrations were assayed by the method of Lowry, Rosebrough, Farr & Randall (1951) . Each preparation was then diluted to a concentration of 2 fig. protein (100 units)/ml. with sterile borate buffered saline (M/15 borate, pH 8-0) containing (g./l.) Na 2 B 4 O 7 .10H 2 O, 3-63; H 3 BO 3 , 5-25; NaCl, 6-19 and Tween 80 at a concentration of 0-0005 %. The diluted antigenic preparations were dispensed through a sterile 0-22 fim. membrane filter into sterile 1 ml. tuberculin vials. Essentially similar reagents have been used in earlier studies (Pritchard, Stanford & Paul, 1974; Stanford, Revill, Gunthorpe & Grange, 1975) .
Multiple skin testing was carried out on leprosy patients and staff at six leprosaria in East Africa. Wherever possible, non-leprosy contacts consisting either of villagers or staff at non-leprosy hospitals in the same areas were also tested. The leprosaria visited were ALERT (All Africa Leprosy and Rehabilitation Training Centre) at Addis Ababa, Ethiopia; Buluba and Nyenga near Lake Victoria in Uganda; Kumi in the Teso district of Uganda; Alupe near Busia in West Kenya and Tumbe on the Kenyan coast (see Table 2 ).
For skin testing 0-2 fig. (0-1 ml.) of reagent was injected intradermally into the front surface of the forearm using Gillette Scimitar 1 ml. syringes fitted with size No. 20 needles. Four tests were performed per person, two on each arm with the injection sites at least If in. apart, using any four of the skin test antigens (see Table 2 ). Reactions were read after 72 hr. by measuring the longitudinal and transverse diameters of induration in mm.
All the injecting and reading was done by the same person (R.C.P.). Information about age, previous BCG vaccination and contact with leprosy or the presence of the disease was recorded for each person. Results for staff and patients below 19 years have been omitted as they formed an unevenly balanced small minority group. The majority of patients were on treatment, and those receiving immunosuppressive reagents have been omitted from this study. The clinical diagnosis of the state of the disease of the leprosy patients was taken as that given by the doctors in charge.
RESULTS
In a preliminary analysis the results for each reagent were found to be very similar for patients categorized as lepromatous (L) or borderline lepromatous (BL) on the one hand and those categorized as tuberculoid (T) or borderline tuberculoid (BT) on the other. Thus the patients were divided into only two groups (L + BL) called lepromatous and (T + BT) called tuberculoid. Since both the numbers of persons in each of the groups tested with each of the reagents and the prevalence of individual mycobacterial species in the environment or of tuberculosis in the local population differed from place to place, the percentages of persons giving various sizes of reaction also differed. For simplicity a certain minimum reaction size has been chosen as 'positive' and results are shown in Table 3 as percentages of persons producing positive reactions. In fact 5 mm. or more was selected as 'positive' since in the cases of the reagents to which a high percentage of persons reacted this diameter fell on the initial 'flat' part of the sigmoid distribution curve (Fig. 1) . To correct for the differences in numbers tested and for differences in the frequency of contact with the various mycobacterial species, graphs have been prepared showing the means of the results for each study group. Examples of these are shown in Figs. 1, 2 and 3 . The mean percentages positive and the means of the average positive reaction sizes for each of the groups tested with each of the reagents are shown in tables 4 and 5.
In none of the groups were the positive reactions to the majority of reagents evenly distributed. The majority were either negative to all four reagents or produced two or more positive responses. The explanation of this pattern does not apparently lie in cross-reaction between the different reagents since patterns of reactivity occurred with differing frequency in the different places and differed from individual to individual. Also the distribution of immunization with BCG 
DISCUSSION
If we interpret a positive skin test as evidence of the ability of the individual to develop delayed hypersensitivity to the organism from which the reagent was prepared, and the percentage of positive reactors to a reagent amongst the healthy population as an index of the allergenicity of the organism and the frequency with which it is encountered, then we have a system for the study of the relation of other mycobacteria to the leprosy bacillus. Of course, this is only the case if the reagents used have some specificity. The evidence we have, only a small amount of which has been published so far (Pritchard et al. 1974; Stanford et al. 1975) or is included in this paper, indicates that our reagents have a considerable degree of specificity. Table 4 , which gives the means of the percentage of positive reactors to each reagent in each leprosarium district for each study group, provides information to which this system can be applied. With the exception of Chelonin which will be discussed later, the percentage of positive reactors was higher in the contact (staff) group than among the leprosy patients in every case (see Figs.  1, 2 and 3) . Although the non-contact groups were in general badly matched, it is interesting to note that with the exception of Nonchromogenicin, Lactin and Vaccin, the percentage of contacts producing positive reactions to each reagent is lower than that of the non-contacts.
The effect of differing percentages of persons immunized with BCG among the study groups could only explain the instances where the contact group and the tubereuloid patient group contain fewer positive reactors than does the noncontact group. The inequality of BCG administration could not explain differences between results for tubereuloid and lepromatous patients or those instances where most positive reactors are amongst the contact or tubereuloid groups.
If we now turn to the differences between the two groups of leprosy patient. and again leave Chelonin for discussion later, reactions fall into 2 categoriess Tuberculin, Aviumin and A*-in show little difference between the groups and the 
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The evidence presented indicates that the immune deficiency of lepromatous leprosy patients does not extend to Tuberculin, Aviumin and A*-in to any great degree but is less specific than was thought hitherto. The immune deficiency to M. leprae also applies to a variable degree to M. gordonae, M. nonchromogenicum, M. engbaekii, M. vaccae, M. fortuitum and M. duvalii. (At this point it should be noted that most of these species are of fast growing mycobacteria.) Additionally the larger number of positive reactors to Nonchromogeniein, Lactin and Vaccin amongst the contact group as compared with the admittedly poorly matched noncontact group suggests some cross-reactivity. The amount of such cross-reactivity is not very great since the percentage of positive reactors is low in each case and there is close similarity between the mean positive reaction diameters (Table 5) of all the groups. Nevertheless our evidence suggests that these species are more closely related to M. leprae than are the others tested.
Mycobacterium vaccae is a fast growing species which is not known to be pathogenic for man or animals. First isolated from the surroundings of cattle (Bonicke & Juhasz, 1964) it is found in occasional milk samples. In our study of mycobacteria from the Ugandan environment (Stanford & Paul, 1973) M. vaccae was only found in the swampy regions around Lake Kyoga (areas similar to those in which the studies of Kinnear Brown & Stone (1966) were performed), although skin test results with Vaccin suggest it is more widespread. M. nonchromogenicum (Tsukamura, 1965) and M. engbaekii (Korsak & Boisvert, 1972) were considered at the beginning of this study to be separate species, the first slow growing and the second fast growing. However, subsequent immunodiffusion analyses have shown them to be variants of a single species which should be placed in the fast growing subgenus. This discovery has provided our study with an unexpected but valuable internal control since the results obtained with the reagents prepared from the two variants are in good agreement. M. nonchromogenicum is a common environmental organism which is not known to cause disease in man or other animals. The relatively low levels of delayed hypersensitivity to this organism despite the frequency of contact with it suggests that it is only feebly allergenicperhaps a further correlation with M. leprae.
The Chelonin results for tuberculoid patients and the contact and non-contact groups are similar to those obtained with other reagents, but the results for the lepromatous group are grossly anomalous (see Fig. 3 ). Chelonin was tested on leprosy patients in three of the hospitals and although only a small number of patients were tested the results are almost identical in each place (Table 3) . One possible explanation is that the lepromatous patients have received many more injections than most people and since M. chelonei is a common cause of injection abscesses in Africa, a number of them might have experienced such infections. Such an explanation would seem improbable. An alternative explanation might be that the reactions recorded as delayed hypersensitivity were in fact persisting Arthus' phenomena in some ways comparable with Erythaema nodosum leprosum and the giant reaction to tuberculin PPD. The finding of easily detectable antibody to one of the antigenic components believed to be specific to M. chelonei in a pool of sera from lepromatous patients in Addis Ababa and in two out of two sera from individual lepromatous patients in Malaysia adds some credence to the latter hypothesis. Obviously further studies must be made on this unexpected finding.
